- Home
- REYN vs AMLX Comparison
REYN vs AMLX Comparison
Compare REYN & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | REYN | AMLX |
|---|---|---|
| Founded | 1947 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Office Equipment/Supplies/Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 3.8B |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | REYN | AMLX |
|---|---|---|
| Price | $21.91 | $28.05 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 12 |
| Target Price | $27.14 | ★ $42.36 |
| AVG Volume (30 Days) | ★ 1.4M | 1.2M |
| Earning Date | 10-28-2026 | 11-05-2026 |
| Dividend Yield | ★ 4.25% | N/A |
| EPS Growth | N/A | ★ 65.46 |
| EPS | ★ 0.28 | N/A |
| Revenue | ★ $3,756,000,000.00 | $380,786,000.00 |
| Revenue This Year | $1.99 | N/A |
| Revenue Next Year | $1.99 | N/A |
| P/E Ratio | $78.77 | ★ N/A |
| Revenue Growth | N/A | ★ 1612.94 |
| 52 Week Low | $20.44 | $10.83 |
| 52 Week High | $27.32 | $41.14 |
Technical Indicators
Market Signals| Indicator | REYN | AMLX |
|---|---|---|
| Relative Strength Index (RSI) | 33.12 | 41.55 |
| Support Level | $20.89 | $12.97 |
| Resistance Level | $22.55 | $34.35 |
| Average True Range (ATR) | 0.49 | 1.41 |
| MACD | 0.08 | -0.72 |
| Stochastic Oscillator | 4.69 | 10.81 |
Price Performance
Historical ComparisonAbout REYN Reynolds Consumer Products Inc.
Reynolds Consumer Products Inc is a provider of household products. The firm is engaged in the production and sales of cooking products, waste and storage products, and tableware. It operates through four reportable segments namely, Reynolds Cooking and Baking, Hefty Waste and Storage, Hefty Tableware, and Presto Products. Reynolds Cooking and Baking segment produce branded and store brand aluminum foil, disposable aluminum pans, parchment paper, freezer paper, wax paper, butcher paper, plastic wrap, baking cups, oven bags and slow cooker liners.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on developing novel therapies for communities with high unmet medical needs. The company has preclinical and clinical development programs in endocrine conditions and neurodegenerative diseases. Its pipeline includes investigational therapies matched with diseases based on mechanistic rationale, clinical outcomes, biomarkers, and preclinical data. The company is currently developing avexitide for Post-Bariatric Hypoglycemia, AMX0035 for Wolfram Syndrome, AMX0114 for Amyotrophic Lateral Sclerosis, and AMX0318 for Post-Bariatric Hypoglycemia and other rare diseases.